These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 903914)

  • 41. Mercaptoalkylamine coordination compounds of platinum(II) and palladium(II) and their anticancer activity.
    Foye WO; Kaewchansilp V
    J Pharm Sci; 1979 Sep; 68(9):1131-5. PubMed ID: 501536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential antitumor agents. 12. 9-Anilinoacridines.
    Atwell GJ; Cain BF; Seelye RN
    J Med Chem; 1972 Jun; 15(6):611-5. PubMed ID: 5030927
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of reductones on glyoxalase I1.
    Iio M; Okabe K; Omura H
    J Nutr Sci Vitaminol (Tokyo); 1976; 22(1):53-61. PubMed ID: 784919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological activity of a new squaric acid-formylmethionine peptide conjugate.
    Kraus JL; Castaing M
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):229-36. PubMed ID: 2587840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.
    Murthy NS; Bakeris T; Kavarana MJ; Hamilton DS; Lan Y; Creighton DJ
    J Med Chem; 1994 Jul; 37(14):2161-6. PubMed ID: 8035422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-activity relationship investigation of bis(2-chloroethyl)aminoethyl esters of some carboxylic acids.
    Pajeva I; Manolov I; Golovinsky EV
    Pharmazie; 1990 May; 45(5):361-3. PubMed ID: 2395899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
    Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS
    Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleic acids. 11. Synthesis of 5'-esters of 1-beta-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity.
    Gish DT; Kelly RC; Camiener GW; Wechter WJ
    J Med Chem; 1971 Dec; 14(12):1159-62. PubMed ID: 5116227
    [No Abstract]   [Full Text] [Related]  

  • 49. N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities.
    Zheng ZB; Zhu G; Tak H; Joseph E; Eiseman JL; Creighton DJ
    Bioconjug Chem; 2005; 16(3):598-607. PubMed ID: 15898727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. pH Dependence of the inhibition of yeast glyoxalase I by porphyrins.
    Douglas KT; Sharif JG
    Biochim Biophys Acta; 1983 Oct; 748(2):184-93. PubMed ID: 6354270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Fluorouracil derivatives. XII. Synthesis and antitumor activity of alpha-alkylthiomethyl-, alpha-alkylsulfinylmethyl-, alpha-alkylsulfonylmethyl-, and alpha-acylthiomethyl-5-fluorouracils.
    Ozaki S; Nagase T; Tamai H; Mori H; Hoshi A; Iigo M
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3894-7. PubMed ID: 3435984
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-Fluorouracil derivatives. X. Synthesis and antitumor activities of alpha-alkoxyalkyl-5-fluorouracils.
    Ozaki S; Watanabe Y; Hoshiko T; Nagase T; Ogasawara T; Furukawa H; Uemura A; Ishikawa K; Mori H; Hoshi A
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):150-7. PubMed ID: 3698125
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibitors of glyoxalase I: design, synthesis, inhibitory characteristics and biological evaluation.
    Allen RE; Lo TW; Thornalley PJ
    Biochem Soc Trans; 1993 May; 21(2):535-40. PubMed ID: 8359527
    [No Abstract]   [Full Text] [Related]  

  • 55. Trapping of reactive intermediates in enzymology. Exogenous flavin reduction during catalytic turnover of substrate by glyoxalase I.
    Douglas KT; Quilter AJ; Shinkai S; Ueda K
    Biochim Biophys Acta; 1985 May; 829(1):119-26. PubMed ID: 3888272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of low doses of lead and cadmium on glyoxalase I and glyoxalase II activities of the liver and brain of rats].
    Winter R; Piskorska D
    Med Pr; 1984; 35(3):177-83. PubMed ID: 6503685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene.
    Lin YT; Loo TL
    J Med Chem; 1972 Feb; 15(2):201-3. PubMed ID: 5008242
    [No Abstract]   [Full Text] [Related]  

  • 58. Depression of polyamine synthesis in L1210 leukemic mice during treatment with a potent antileukemic agent, 5-azacytidine.
    Heby O; Russell DH
    Cancer Res; 1973 Jan; 33(1):159-65. PubMed ID: 4118428
    [No Abstract]   [Full Text] [Related]  

  • 59. The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules.
    Doweyko AM
    J Med Chem; 1988 Jul; 31(7):1396-406. PubMed ID: 3290487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allylic esters as potential antitumor agents. Derivatives and analogues of 2,3-bis(hydroxymethyl)-7-oxabicyclo[2.2.1]hept-2-ene.
    Anderson WK; Dewey RH; Mulumba B
    J Med Chem; 1979 Oct; 22(10):1270-2. PubMed ID: 513076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.